Sep 3, 2025
Ethambutol in Latent TB Infection (LTBI): When It’s Used and When It’s Not
Biosimilars offer major cost savings over brand-name biologics, but insurance barriers like prior authorization and same-tier placement make them hard to access. Patients pay nearly the same out-of-pocket costs - defeating the purpose.